BM
Buyukbayram, Mehmet E.
3 yayın · 34 atıf · 2021–2022
Yayın
3
Atıf
34
Yıllar
2
Yayınlar
| Başlık | Yıl | Tip | Atıf |
|---|---|---|---|
|
Reply to John L. Frater's letter to the editor: Use of laboratory hematology data in melanoma research: comments on 'A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio'
|
2022 | Letter | 0 |
|
A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio
|
2021 | Article | 13 |
|
The importance of the glucose-to-lymphocyte ratio in patients with hepatocellular carcinoma treated with sorafenib
|
2021 | Article | 21 |